Cargando…
Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab
Patients with pre-existing comorbidities and immunosuppression are at greater risk for SARS-CoV-2 infection and severe manifestations of COVID-19. This also includes cancer patients, who are shown to have a poor prognosis after infection. Here, we describe the case of a 72-year old male patient with...
Autores principales: | Kos, Igor, Balensiefer, Benedikt, Roth, Sophie, Ahlgrimm, Manfred, Sester, Martina, Schmidt, Tina, Thurner, Lorenz, Bewarder, Moritz, Bals, Robert, Lammert, Frank, Stilgenbauer, Stephan, Kaddu-Mulindwa, Dominic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493633/ https://www.ncbi.nlm.nih.gov/pubmed/32984017 http://dx.doi.org/10.3389/fonc.2020.01578 |
Ejemplares similares
-
Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients
por: Kos, Igor, et al.
Publicado: (2021) -
Current Treatment Options in CLL
por: Bewarder, Moritz, et al.
Publicado: (2021) -
Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2021) -
Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives
por: Kaddu-Mulindwa, Dominic, et al.
Publicado: (2022) -
Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies
por: Christofyllakis, Konstantinos, et al.
Publicado: (2023)